CGEM
Cullinan Therapeutics, Inc.
Company overview
- Market capitalization
- $962.10M
- Employees
- 109
- Latest publication
- 2026-09-29
About Cullinan Therapeutics, Inc.
Cullinan Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for autoimmune diseases and cancer in the United States. It engages in the development of CLN-978, a CD19xCD3 bispecific T cell engager for autoimmune diseases in Phase 1 clinical trials; Velinotamig, a BCMAxCD3 bispecific T cell in Phase 1 clinical trials in patients with autoimmune diseases; and CLN-049, a FLT3xCD3 bispecific T cell engager, which is in Phase 1 clinical trials in patients with relapsed and refractory acute myeloid leukemia or myelodysplastic syndrome. The company is also developing Zipalertinib, an orally available small-molecule, irreversible epidermal growth factor receptor inhibitor in Phase 2b portion of the REZILIENT1 clinical trial in patients with EGFR ex20ins non-small cell lung cancer. It has a license agreement with Chongqing Genrix Biopharmaceutical Co., Ltd to develop and commercialize velinotamig; a co-development agreement with Taiho Pharmaceutical Co., Ltd to develop zipalertinib; and a collaboration agreement with Adimab, LLC to discover and/or optimize antibodies. The company was formerly known as Cullinan Oncology, Inc. and changed its name to Cullinan Therapeutics, Inc. in April 2024. Cullinan Therapeutics, Inc. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 79,000USD | 79,000USD | — | 77,000USD | 76,000USD | 77,000USD | 76,000USD | 77,000USD |
| Gross Profit | -79,000USD | -79,000USD | — | -77,000USD | -76,000USD | -77,000USD | -76,000USD | -77,000USD |
| Research Development | 42,123,000USD | 42,945,000USD | 41,968,000USD | 61,030,000USD | 41,459,000USD | 40,492,000USD | 35,506,000USD | 36,259,000USD |
| Selling General Administrative | 11,574,000USD | 12,314,000USD | 13,627,000USD | 14,768,000USD | 13,537,000USD | 14,556,000USD | 13,349,000USD | 13,768,000USD |
| Total Operating Expenses | 53,697,000USD | 55,259,000USD | 55,595,000USD | 75,798,000USD | 54,996,000USD | 55,048,000USD | 48,855,000USD | 49,950,000USD |
| Operating Income | -53,697,000USD | -55,259,000USD | -55,595,000USD | -75,798,000USD | -54,996,000USD | -55,048,000USD | -48,855,000USD | -50,027,000USD |
| Interest Income | 4,098,000USD | 4,615,000USD | 5,093,000USD | 5,924,000USD | 6,580,000USD | 7,512,000USD | 8,384,000USD | 8,071,000USD |
| Net Interest Income | 4,098,000USD | 4,615,000USD | 5,093,000USD | 5,924,000USD | 6,580,000USD | 7,512,000USD | 8,384,000USD | 8,071,000USD |
| Income Before Tax | -49,661,000USD | -50,713,000USD | -50,610,000USD | -70,055,000USD | -48,501,000USD | -47,530,000USD | -40,560,000USD | -42,028,000USD |
| Net Income | -49,661,000USD | -50,713,000USD | -50,610,000USD | -70,055,000USD | -48,501,000USD | -47,647,000USD | -40,560,000USD | -42,028,000USD |
| Net Income From Continuing Ops | -49,661,000USD | -50,713,000USD | -50,610,000USD | -70,055,000USD | -48,501,000USD | -47,647,000USD | -40,560,000USD | -42,028,000USD |
| Ebit | -49,661,000USD | -50,713,000USD | -50,610,000USD | -70,055,000USD | -48,501,000USD | -47,530,000USD | -40,560,000USD | -42,028,000USD |
| Ebitda | -49,582,000USD | -50,634,000USD | -50,531,000USD | -69,978,000USD | -48,425,000USD | -47,453,000USD | -40,484,000USD | -41,951,000USD |
| Depreciation And Amortization | 79,000USD | 79,000USD | 79,000USD | 77,000USD | 76,000USD | 77,000USD | 76,000USD | 77,000USD |
| Reconciled Depreciation | 79,000USD | 79,000USD | 79,000USD | 77,000USD | 76,000USD | 77,000USD | 76,000USD | 77,000USD |
| Total Other Income Expense Net | 4,036,000USD | 4,546,000USD | 4,985,000USD | 5,743,000USD | 6,495,000USD | 7,518,000USD | 8,295,000USD | 7,999,000USD |
| Minority Interest | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Income Tax Expense | — | — | — | — | — | 117,000USD | — | — |
| Selling And Marketing Expenses | — | — | — | — | — | — | — | 77,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD | FY 20162016-12-31 · USD | FY 20152015-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 18,943,000USD | 18,943,000USD | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 311,000USD | 306,000USD | 53,000USD | 62,000USD | 70,000USD | 43,000USD | 0USD | 0USD |
| Gross Profit | -311,000USD | -306,000USD | 18,943,000USD | -62,000USD | -70,000USD | -43,000USD | 0USD | 0USD |
| Research Development | 187,402,000USD | 142,903,000USD | 57,751,000USD | 43,211,000USD | 16,788,000USD | 9,584,000USD | — | — |
| Selling General Administrative | 54,246,000USD | 52,816,000USD | 29,146,000USD | 17,124,000USD | 5,482,000USD | 5,002,000USD | 197,397USD | 95,438USD |
| Total Operating Expenses | 241,648,000USD | 196,613,000USD | 86,897,000USD | 60,335,000USD | 22,270,000USD | 14,586,000USD | 197,397USD | 95,438USD |
| Operating Income | -241,648,000USD | -196,919,000USD | -67,954,000USD | -60,335,000USD | -22,270,000USD | -14,586,000USD | -197,397USD | -95,438USD |
| Interest Income | 22,212,000USD | 29,660,000USD | 477,000USD | 888,000USD | 620,000USD | 397,000USD | — | — |
| Net Interest Income | 22,212,000USD | 29,660,000USD | 477,000USD | 888,000USD | 620,000USD | 397,000USD | — | — |
| Income Before Tax | -219,879,000USD | -167,458,000USD | -67,485,000USD | -59,458,000USD | -21,654,000USD | -14,189,000USD | -316,703USD | -109,510USD |
| Tax Provision | 0USD | 117,000USD | 0USD | — | — | — | — | — |
| Net Income | -219,879,000USD | -167,383,000USD | -65,040,000USD | -50,849,000USD | -20,037,000USD | -14,189,000USD | -316,703USD | -109,510USD |
| Net Income From Continuing Ops | -219,879,000USD | -167,575,000USD | -65,570,000USD | -59,458,000USD | -21,654,000USD | -14,189,000USD | -316,703USD | -109,510USD |
| Ebit | -219,879,000USD | -167,458,000USD | -67,954,000USD | -60,335,000USD | -22,270,000USD | -14,586,000USD | -197,397USD | -95,438USD |
| Ebitda | -219,568,000USD | -167,152,000USD | -67,901,000USD | -60,273,000USD | -22,200,000USD | -14,543,000USD | — | — |
| Depreciation And Amortization | 311,000USD | 306,000USD | 53,000USD | 62,000USD | 70,000USD | 43,000USD | — | — |
| Reconciled Depreciation | 311,000USD | 306,000USD | 53,000USD | 62,000USD | 70,000USD | 43,000USD | — | — |
| Total Other Income Expense Net | 21,769,000USD | 29,461,000USD | 469,000USD | 877,000USD | 616,000USD | 397,000USD | -119,306USD | -14,072USD |
| Minority Interest | 0USD | 192,000USD | -1,915,000USD | 1,304,000USD | 864,000USD | 1,000USD | — | — |
| Selling And Marketing Expenses | — | 894,000USD | — | — | — | — | — | — |
| Income Tax Expense | — | 117,000USD | -2,445,000USD | -8,609,000USD | -1,617,000USD | 397,000USD | 0USD | 0USD |
| Interest Expense | — | — | 65,449,515USD | 888,000USD | 0USD | 0USD | 0USD | 0USD |
| Non Operating Income Net Other | — | — | 469,000USD | — | — | — | — | — |
| Net Income Applicable To Common Shares | — | — | -65,570,000USD | -51,799,000USD | -20,657,000USD | -14,189,000USD | -316,703USD | -109,510USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 363,787,000USD | 402,984,000USD | 448,374,000USD | 484,126,000USD | 520,329,000USD | 579,681,000USD | 621,824,000USD | 653,254,000USD |
| Cash And Equivalents | 78,640,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 334,538,000USD | 351,885,000USD | 377,896,000USD | 332,596,000USD | 265,482,000USD | 303,827,000USD | 398,977,000USD | 578,078,000USD |
| Short Term Investments | 255,898,000USD | 276,804,000USD | 289,564,000USD | 229,261,000USD | 192,662,000USD | 227,172,000USD | 315,972,000USD | 475,993,000USD |
| Long Term Investments | 19,020,000USD | 38,501,000USD | 58,270,000USD | 139,995,000USD | 242,302,000USD | 259,386,000USD | 204,440,000USD | 57,976,000USD |
| Total Current Assets | 341,974,000USD | 361,407,000USD | 386,756,000USD | 342,235,000USD | 275,911,000USD | 317,772,000USD | 414,668,000USD | 592,039,000USD |
| Other Non Current Assets | 297,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 42,033,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 40,628,000USD | 35,154,000USD | 37,741,000USD | 32,757,000USD | 28,058,000USD | 27,349,000USD | 30,647,000USD | 24,204,000USD |
| Other Current Liabilities | 36,237,000USD | — | — | — | — | — | — | — |
| Total Equity Including Noncontrolling Interest | 321,754,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 2,496,000USD | 2,779,000USD | 3,051,000USD | 1,535,000USD | 1,749,000USD | 2,157,000USD | 2,350,000USD | 2,779,000USD |
| Accounts Payable | 3,725,000USD | 2,509,000USD | 841,000USD | 1,722,000USD | 2,461,000USD | 3,401,000USD | 1,682,000USD | 2,115,000USD |
| Short Term Debt | 666,000USD | 725,000USD | 780,000USD | 1,188,000USD | 1,394,000USD | 1,347,000USD | 1,302,000USD | 1,258,000USD |
| Common Stock | 6,000USD | 6,000USD | 6,000USD | 6,000USD | 6,000USD | 6,000USD | 6,000USD | 6,000USD |
| Retained Earnings | -691,484,000USD | -637,780,000USD | -588,119,000USD | -537,406,000USD | -486,796,000USD | -416,741,000USD | -368,240,000USD | -320,593,000USD |
| Accumulated Other Comprehensive Income | -134,000USD | 127,000USD | 1,020,000USD | 973,000USD | 607,000USD | 505,000USD | -133,000USD | 970,000USD |
| Other Current Assets | — | 9,522,000USD | 8,860,000USD | 9,639,000USD | 10,429,000USD | 13,945,000USD | 12,691,000USD | 13,961,000USD |
| Total Liab | — | 36,812,000USD | 39,644,000USD | 32,757,000USD | 28,183,000USD | 27,842,000USD | 31,496,000USD | 25,392,000USD |
| Total Stockholder Equity | — | 366,172,000USD | 408,730,000USD | 451,369,000USD | 492,146,000USD | 551,839,000USD | 590,328,000USD | 627,862,000USD |
| Other Current Liab | — | 31,920,000USD | 36,120,000USD | 29,847,000USD | 24,203,000USD | 22,601,000USD | 27,663,000USD | 20,831,000USD |
| Capital Stock | — | 6,000USD | 6,000USD | 6,000USD | 6,000USD | 6,000USD | 6,000USD | 6,000USD |
| Cash | — | 75,081,000USD | 88,332,000USD | 103,335,000USD | 72,820,000USD | 76,655,000USD | 83,005,000USD | 102,085,000USD |
| Net Debt | — | -72,698,000USD | -85,649,000USD | -102,147,000USD | -71,301,000USD | -74,815,000USD | -80,854,000USD | -99,639,000USD |
| Short Long Term Debt Total | — | 2,383,000USD | 2,683,000USD | 1,188,000USD | 1,519,000USD | 1,840,000USD | 2,151,000USD | 2,446,000USD |
| Property Plant Equipment Gross | — | 2,779,000USD | 4,020,000USD | 1,535,000USD | 1,749,000USD | 2,157,000USD | 3,008,000USD | 2,779,000USD |
| Common Stock Shares Outstanding | — | 59,201,000shares | 59,201,000shares | 59,015,000shares | 59,015,000shares | 58,905,000shares | 58,580,000shares | 58,337,000shares |
| Non Current Assets Total | — | 41,577,000USD | 61,618,000USD | 141,891,000USD | 244,418,000USD | 261,909,000USD | 207,156,000USD | 61,215,000USD |
| Non Current Liabilities Total | — | 1,658,000USD | 1,903,000USD | 0USD | 125,000USD | 493,000USD | 849,000USD | 1,188,000USD |
| Non Currrent Assets Other | — | 297,000USD | 297,000USD | 361,000USD | 367,000USD | 366,000USD | 366,000USD | 460,000USD |
| Net Working Capital | — | 326,253,000USD | 349,015,000USD | 309,478,000USD | 247,853,000USD | 290,423,000USD | 384,021,000USD | 567,835,000USD |
| Unclassified Non Current Liabilities | — | 1,658,000USD | 1,903,000USD | — | — | — | — | 1,188,000USD |
| Unclassified Equity | — | 1,003,813,000USD | 995,817,000USD | 987,790,000USD | 978,323,000USD | 968,063,000USD | 958,689,000USD | 947,473,000USD |
| Net Receivables | — | — | — | — | — | — | 3,000,000USD | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 448,374,000USD | 621,824,000USD | 484,182,000USD | 561,117,000USD | 437,185,000USD | 214,708,000USD | 100,461,000USD | 34,640,000USD |
| Other Current Assets | 8,860,000USD | 12,691,000USD | 13,124,000USD | 7,180,000USD | 6,098,000USD | 2,072,000USD | 1,461,000USD | 387,000USD |
| Total Liab | 39,644,000USD | 31,496,000USD | 30,287,000USD | 26,088,000USD | 11,811,000USD | 14,394,000USD | 140,370,000USD | 55,290,000USD |
| Total Stockholder Equity | 408,730,000USD | 590,328,000USD | 453,703,000USD | 535,029,000USD | 424,971,000USD | 199,010,000USD | -40,773,000USD | -20,651,000USD |
| Other Current Liab | 36,120,000USD | 27,663,000USD | 24,204,000USD | 13,957,000USD | 8,577,000USD | 4,641,000USD | 1,589,000USD | 1,028,000USD |
| Common Stock | 6,000USD | 6,000USD | 4,000USD | 5,000USD | 4,000USD | 3,000USD | 1,000USD | 1,000USD |
| Capital Stock | 6,000USD | 6,000USD | 4,000USD | 5,000USD | 4,000USD | 1,000USD | 1,000USD | 1,000USD |
| Retained Earnings | -588,119,000USD | -368,240,000USD | -200,857,000USD | -47,695,000USD | -158,909,000USD | -93,339,000USD | -41,540,000USD | -20,866,000USD |
| Cash | 88,332,000USD | 83,005,000USD | 98,434,000USD | 156,152,000USD | 59,774,000USD | 168,198,000USD | 63,250,000USD | 33,832,000USD |
| Cash And Short Term Investments | 377,896,000USD | 398,977,000USD | 467,067,000USD | 467,292,000USD | 290,466,000USD | 210,206,000USD | 98,630,000USD | 33,832,000USD |
| Total Current Assets | 386,756,000USD | 414,668,000USD | 480,191,000USD | 474,472,000USD | 296,564,000USD | 212,278,000USD | 100,091,000USD | 34,219,000USD |
| Total Current Liabilities | 37,741,000USD | 30,647,000USD | 28,137,000USD | 22,498,000USD | 11,746,000USD | 14,320,000USD | 2,523,000USD | 1,324,000USD |
| Net Debt | -85,649,000USD | -80,854,000USD | -94,844,000USD | -150,963,000USD | -59,774,000USD | -168,198,000USD | -63,250,000USD | -33,832,000USD |
| Short Term Debt | 780,000USD | 1,302,000USD | 1,440,000USD | 1,599,000USD | — | — | — | — |
| Short Long Term Debt Total | 2,683,000USD | 2,151,000USD | 3,590,000USD | 5,189,000USD | — | — | — | — |
| Long Term Investments | 58,270,000USD | 204,440,000USD | 0USD | 80,882,000USD | 140,397,000USD | 0USD | — | — |
| Short Term Investments | 289,564,000USD | 315,972,000USD | 368,633,000USD | 311,140,000USD | 230,692,000USD | 42,008,000USD | 35,380,000USD | 0USD |
| Accounts Payable | 841,000USD | 1,682,000USD | 2,493,000USD | 2,660,000USD | 3,169,000USD | 9,679,000USD | 934,000USD | 296,000USD |
| Property Plant Equipment Net | 3,051,000USD | 2,350,000USD | 3,532,000USD | 5,304,000USD | 77,000USD | 130,000USD | 182,000USD | 233,000USD |
| Property Plant Equipment Gross | 4,020,000USD | 3,008,000USD | 3,884,000USD | 5,439,000USD | 309,000USD | 130,000USD | 182,000USD | 233,000USD |
| Accumulated Other Comprehensive Income | 1,020,000USD | -133,000USD | -129,000USD | -2,601,000USD | -838,000USD | -2,000USD | -4,000USD | 1,000USD |
| Common Stock Shares Outstanding | 59,050,000shares | 53,771,000shares | 41,550,000shares | 46,640,000shares | 44,292,000shares | 43,516,000shares | 1,017,883shares | 800,038shares |
| Non Current Assets Total | 61,618,000USD | 207,156,000USD | 3,991,000USD | 86,645,000USD | 140,621,000USD | 2,430,000USD | 370,000USD | 421,000USD |
| Non Current Liabilities Total | 1,903,000USD | 849,000USD | 2,150,000USD | 3,590,000USD | 65,000USD | 74,000USD | 137,847,000USD | 53,966,000USD |
| Non Currrent Assets Other | 297,000USD | 366,000USD | 459,000USD | 459,000USD | 147,000USD | 2,300,000USD | 188,000USD | 188,000USD |
| Net Working Capital | 349,015,000USD | 384,021,000USD | 452,054,000USD | 451,974,000USD | 284,818,000USD | 197,958,000USD | 97,568,000USD | 32,895,000USD |
| Unclassified Non Current Liabilities | 1,903,000USD | — | 2,150,000USD | 3,590,000USD | — | -2,200,000USD | 137,774,000USD | 53,902,000USD |
| Unclassified Equity | 995,817,000USD | 958,689,000USD | 654,681,000USD | 585,315,000USD | 584,710,000USD | 292,347,000USD | — | — |
| Net Receivables | — | 3,000,000USD | 5,400,000USD | — | — | — | — | — |
| Other Assets | — | — | 0USD | 459,000USD | 6,322,000USD | 2,300,000USD | 188,000USD | 188,000USD |
| Inventory | — | — | -5,400,000USD | — | — | — | — | — |
| Unclassified Current Assets | — | — | -5,400,000USD | — | — | — | — | — |
| Short Long Term Debt | — | — | — | 178,000USD | — | — | — | — |
| Net Tangible Assets | — | — | — | 535,029,000USD | 424,971,000USD | -77,642,000USD | -40,773,000USD | -20,651,000USD |
| Unclassified Current Liabilities | — | — | — | 4,104,000USD | — | — | — | — |
| Deferred Long Term Liab | — | — | — | — | 65,000USD | 2,200,000USD | — | — |
| Other Liab | — | — | — | — | 65,000USD | 74,000USD | 73,000USD | 64,000USD |
| Unclassified Non Current Assets | — | — | — | — | -6,322,000USD | -2,300,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -49,661,000USD | -50,713,000USD | -50,610,000USD | -70,055,000USD | -48,501,000USD | -47,647,000USD | -40,560,000USD | -42,028,000USD |
| Depreciation | 79,000USD | 79,000USD | 79,000USD | 77,000USD | 76,000USD | 77,000USD | 76,000USD | 77,000USD |
| Stock Based Compensation | 7,616,000USD | 7,312,000USD | 9,467,000USD | 9,887,000USD | 9,374,000USD | 9,634,000USD | 9,430,000USD | 10,533,000USD |
| Other Non Cash Items | -777,000USD | -931,000USD | -1,358,000USD | -1,706,000USD | -2,311,000USD | -3,511,000USD | -4,927,000USD | -3,725,000USD |
| Change In Working Capital | -3,302,000USD | 6,144,000USD | 5,545,000USD | 4,188,000USD | -1,793,000USD | 4,821,000USD | 1,842,000USD | -1,148,000USD |
| Total Cash From Operating Activities | -46,045,000USD | -38,109,000USD | -36,877,000USD | -57,609,000USD | -43,155,000USD | -36,626,000USD | -34,139,000USD | -36,291,000USD |
| Capital Expenditures | 0USD | -11,000USD | -36,877,000USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Free Cash Flow | -46,045,000USD | -38,120,000USD | -36,915,000USD | -57,609,000USD | -43,155,000USD | -36,626,000USD | -34,139,000USD | -36,291,000USD |
| Investments | 32,414,000USD | 22,402,000USD | 67,392,000USD | 53,401,000USD | 36,805,000USD | 15,964,000USD | 19,878,000USD | -185,112,000USD |
| Total Cashflows From Investing Activities | 32,414,000USD | 22,391,000USD | 67,392,000USD | 53,401,000USD | 36,805,000USD | 15,964,000USD | 19,878,000USD | -185,112,000USD |
| Total Cash From Financing Activities | 380,000USD | 715,000USD | 0USD | 373,000USD | 0USD | 1,582,000USD | 1,325,000USD | 262,196,000USD |
| Change In Cash | -13,251,000USD | -15,003,000USD | 30,515,000USD | -3,835,000USD | -6,350,000USD | -19,080,000USD | -12,936,000USD | 40,793,000USD |
| Begin Period Cash Flow | 88,332,000USD | 103,335,000USD | 72,820,000USD | 76,655,000USD | 83,005,000USD | 102,085,000USD | 115,021,000USD | 74,228,000USD |
| End Period Cash Flow | 75,081,000USD | 88,332,000USD | 103,335,000USD | 72,820,000USD | 76,655,000USD | 83,005,000USD | 102,085,000USD | 115,021,000USD |
| Issuance Of Capital Stock | — | 0USD | 0USD | — | — | 0USD | 0USD | — |
| Other Cashflows From Financing Activities | — | 715,000USD | — | 373,000USD | — | 1,582,000USD | -656,000USD | -3,792,000USD |
| Other Cashflows From Investing Activities | — | — | -38,000USD | — | — | — | — | -185,112,000USD |
| Unclassified Investing Cash Flow | — | — | 36,915,000USD | — | — | — | — | 185,112,000USD |
| Net Borrowings | — | — | — | — | — | 0USD | 0USD | — |
| Unclassified Financing Cash Flow | — | — | — | — | — | — | 1,981,000USD | 265,988,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD | FY 20162016-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -219,879,000USD | -167,575,000USD | -153,162,000USD | 109,195,000USD | -51,799,000USD | -20,657,000USD | -14,189,000USD | -316,703USD |
| Depreciation | 311,000USD | 306,000USD | 310,000USD | 93,000USD | 62,000USD | 70,000USD | 43,000USD | — |
| Stock Based Compensation | 36,040,000USD | 37,824,000USD | 30,438,000USD | 27,957,000USD | 14,910,000USD | 17,000USD | — | — |
| Other Non Cash Items | -6,306,000USD | -15,469,000USD | -11,522,000USD | -275,085,000USD | 15,114,000USD | -445,000USD | 252,000USD | — |
| Change In Working Capital | 14,084,000USD | -389,000USD | -339,000USD | 11,176,000USD | 6,851,000USD | 135,000USD | 345,000USD | 85,432USD |
| Total Cash From Operating Activities | -175,750,000USD | -145,303,000USD | -134,275,000USD | -126,664,000USD | -29,772,000USD | -20,897,000USD | -13,549,000USD | -228,911USD |
| Capital Expenditures | -49,000USD | 0USD | -208,000USD | -1,133,000USD | -10,000USD | -20,000USD | -261,000USD | 0USD |
| Free Cash Flow | -175,799,000USD | -145,303,000USD | -134,483,000USD | -127,797,000USD | -29,782,000USD | -20,917,000USD | -13,810,000USD | — |
| Investments | 180,038,000USD | -136,314,000USD | 35,806,000USD | -24,983,000USD | -6,860,000USD | -35,400,000USD | -261,000USD | — |
| Total Cashflows From Investing Activities | 179,989,000USD | -136,314,000USD | 35,806,000USD | 248,975,000USD | -5,420,000USD | -35,400,000USD | -261,000USD | — |
| Total Cash From Financing Activities | 1,088,000USD | 266,188,000USD | 40,751,000USD | -25,933,000USD | 140,140,000USD | 85,715,000USD | -29,000USD | 228,884USD |
| Issuance Of Capital Stock | 0USD | 262,652,000USD | 38,388,000USD | 38,388,000USD | 139,091,000USD | 84,250,000USD | 1,000USD | — |
| Change In Cash | 5,327,000USD | -15,429,000USD | -57,718,000USD | 96,378,000USD | 104,948,000USD | 29,418,000USD | -13,839,000USD | -27USD |
| Begin Period Cash Flow | 83,005,000USD | 98,434,000USD | 156,152,000USD | 59,774,000USD | 63,250,000USD | 33,832,000USD | 47,671,000USD | — |
| End Period Cash Flow | 88,332,000USD | 83,005,000USD | 98,434,000USD | 156,152,000USD | 168,198,000USD | 63,250,000USD | 33,832,000USD | 47,671,000USD |
| Other Cashflows From Financing Activities | 1,088,000USD | 3,536,000USD | 538,000USD | -32,128,000USD | 138,878,000USD | 85,715,000USD | -30,000USD | — |
| Net Borrowings | — | 0USD | 1,825,000USD | -2,200,000USD | 175,000USD | 175,000USD | — | -757,768USD |
| Other Cashflows From Investing Activities | — | — | 36,014USD | 91,000USD | -5,410USD | -35,380USD | 1,450,000USD | — |
| Change To Liabilities | — | — | — | 12,306,000USD | 5,581,000USD | 639,000USD | 225,000USD | 88,776USD |
| Sale Purchase Of Stock | — | — | — | -23,733,000USD | -213,000USD | -378,000USD | -21,000USD | 986,652USD |
| Cash And Cash Equivalents Changes | — | — | — | 96,378,000USD | — | — | — | — |
| Unclassified Investing Cash Flow | — | — | — | 275,000,000USD | 1,455,410USD | — | -1,189,000USD | — |
| Unclassified Financing Cash Flow | — | — | — | 32,128,000USD | — | — | — | — |
| Unclassified Operating Cash Flow | — | — | — | — | -14,910,000USD | — | — | — |
| Change To Account Receivables | — | — | — | — | — | — | — | -3,344USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.